Sklavenitis-Pistofidis R, Konishi Y, Heilpern-Mallory D, Wu T, Tsakmaklis N, Aranha M
Nat Commun. 2025; 16(1):1480.
PMID: 39929803
PMC: 11811135.
DOI: 10.1038/s41467-025-56323-w.
Patel N, Al Hadidi S, Yellapragada S
Clin Hematol Int. 2024; 6(4):11-18.
PMID: 39417016
PMC: 11477924.
DOI: 10.46989/001c.124268.
Yan Y, Yu Y, Xiong W, Wang J, Yao Y, Jia Y
Clin Cancer Res. 2024; 30(23):5483-5493.
PMID: 39373694
PMC: 11609624.
DOI: 10.1158/1078-0432.CCR-23-3939.
Huang Y, Xiong W, Yuan J, Yu Y, Li Y, Yan Y
Zhonghua Xue Ye Xue Za Zhi. 2024; 45(8):755-760.
PMID: 39307722
PMC: 11535557.
DOI: 10.3760/cma.j.cn121090-20240301-00077.
Bibas M, Sarosiek S, Castillo J
Mediterr J Hematol Infect Dis. 2024; 16(1):e2024061.
PMID: 38984103
PMC: 11232678.
DOI: 10.4084/MJHID.2024.061.
Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis.
Wolf E, Imperial R, Jiang L, Agarwal A, Tun H
J Blood Med. 2024; 15:291-303.
PMID: 38947230
PMC: 11212808.
DOI: 10.2147/JBM.S459123.
A Rare Case of Non-IgM Lymphoplasmacytic Lymphoma with Unusual Lack of Immunoglobulin Light Chain Production.
Yin J, Bains A, Alsammak M, Fu J
Am J Case Rep. 2024; 25:e940963.
PMID: 38437184
PMC: 10926237.
DOI: 10.12659/AJCR.940963.
How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia.
Treon S, Sarosiek S, Castillo J
Blood. 2024; 143(17):1702-1712.
PMID: 38211337
PMC: 11103089.
DOI: 10.1182/blood.2022017235.
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.
Song Y, Wu S, Shen Z, Zhao D, Chan T, Huang H
Exp Hematol Oncol. 2023; 12(1):92.
PMID: 37845755
PMC: 10578030.
DOI: 10.1186/s40164-023-00448-5.
Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis.
Chan W, Chong V, Wee I, Poon L, Chan E, Lee J
Blood Cancer J. 2023; 13(1):140.
PMID: 37679351
PMC: 10485051.
DOI: 10.1038/s41408-023-00916-5.
Current approach to Waldenström macroglobulinemia.
Kapoor P, Rajkumar S
Blood Rev. 2023; 62:101129.
PMID: 37659912
PMC: 10841191.
DOI: 10.1016/j.blre.2023.101129.
Analysis of genomic alterations in primary central nervous system lymphoma.
He X, Fan X, Shan Y, Ji X, Su L, Wang Y
Medicine (Baltimore). 2023; 102(35):e34931.
PMID: 37657032
PMC: 10476858.
DOI: 10.1097/MD.0000000000034931.
Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia.
Cholujova D, Beke G, Hunter Z, Hideshima T, Flores L, Zeleznikova T
Int J Cancer. 2022; 152(9):1947-1963.
PMID: 36533670
PMC: 9992277.
DOI: 10.1002/ijc.34405.
Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders.
Savino F, Rigali F, Giustini V, DAliberti D, Spinelli S, Piazza R
Cancers (Basel). 2022; 14(21).
PMID: 36358796
PMC: 9654765.
DOI: 10.3390/cancers14215378.
Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia.
Lim J, Wang J, Webb F, Saxena K, Enosi Tuipulotu D, Pandey A
iScience. 2022; 25(8):104856.
PMID: 35992066
PMC: 9389254.
DOI: 10.1016/j.isci.2022.104856.
Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.
Alcoceba M, Garcia-Alvarez M, Medina A, Maldonado R, Gonzalez-Calle V, Chillon M
Int J Mol Sci. 2022; 23(10).
PMID: 35628381
PMC: 9141891.
DOI: 10.3390/ijms23105570.
Application of precision medicine in clinical routine in haematology-Challenges and opportunities.
Wasterlid T, Cavelier L, Haferlach C, Konopleva M, Frohling S, Ostling P
J Intern Med. 2022; 292(2):243-261.
PMID: 35599019
PMC: 9546002.
DOI: 10.1111/joim.13508.
Genomic landscape of Waldenström's macroglobulinemia.
Treon S, Hunter Z, Branagan A, Castillo J
Hemasphere. 2022; 3(Suppl).
PMID: 35309816
PMC: 8925683.
DOI: 10.1097/HS9.0000000000000228.
Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia.
Piazza F, Di Paolo V, Scapinello G, Manni S, Trentin L, Quintieri L
Front Oncol. 2022; 11:801124.
PMID: 35087759
PMC: 8787211.
DOI: 10.3389/fonc.2021.801124.
How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen.
Cabecadas J, Nava V, Ascensao J, Gomes Da Silva M
Curr Oncol. 2021; 28(6):4611-4633.
PMID: 34898558
PMC: 8628806.
DOI: 10.3390/curroncol28060390.
